Quinapril

Quinapril is a pharmaceutical-grade active ingredient classified as an ACE Inhibitor Antihypertensive. Mediocon Inc supplies high-purity Quinapril API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Quinapril is a prodrug ACE inhibitor hydrolyzed in vivo to its active metabolite quinaprilat. It is used for the treatment of hypertension and heart failure. By inhibiting ACE, it reduces angiotensin II formation, causing vasodilation and decreased aldosterone secretion.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Hypertension management
• Heart failure treatment
• Diabetic nephropathy protection
• Post-myocardial infarction cardiac remodeling

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings